Endurance Wealth Management Inc. continued to hold its position in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) during the 2nd quarter, according to its most recent disclosure with the SEC. The fund owned 25,143 shares of the pharmacy operator’s stock at the end of the 2nd quarter. Endurance Wealth Management Inc.’s holdings in Walgreens Boots Alliance were worth $1,969,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in WBA. Reilly Financial Advisors LLC grew its position in shares of Walgreens Boots Alliance by 7.9% during the 2nd quarter. Reilly Financial Advisors LLC now owns 1,367 shares of the pharmacy operator’s stock worth $107,000 after purchasing an additional 100 shares in the last quarter. Tarbox Group Inc. increased its holdings in shares of Walgreens Boots Alliance by 288.3% during the first quarter. Tarbox Group Inc. now owns 1,355 shares of the pharmacy operator’s stock worth $113,000 after purchasing an additional 1,006 shares during the period. Webster Bank N. A. increased its holdings in shares of Walgreens Boots Alliance by 18.4% during the first quarter. Webster Bank N. A. now owns 1,509 shares of the pharmacy operator’s stock worth $125,000 after purchasing an additional 235 shares during the period. Orrstown Financial Services Inc. increased its holdings in shares of Walgreens Boots Alliance by 14.1% during the second quarter. Orrstown Financial Services Inc. now owns 1,728 shares of the pharmacy operator’s stock worth $135,000 after purchasing an additional 213 shares during the period. Finally, MCF Advisors LLC raised its position in shares of Walgreens Boots Alliance by 68.2% in the first quarter. MCF Advisors LLC now owns 1,923 shares of the pharmacy operator’s stock valued at $160,000 after buying an additional 780 shares in the last quarter. Institutional investors and hedge funds own 60.16% of the company’s stock.

Shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) opened at 77.22 on Monday. The company’s 50-day moving average price is $81.36 and its 200-day moving average price is $81.86. Walgreens Boots Alliance, Inc. has a 12 month low of $75.18 and a 12 month high of $89.69. The company has a market cap of $82.63 billion, a price-to-earnings ratio of 19.50 and a beta of 1.26.

Walgreens Boots Alliance (NASDAQ:WBA) last released its quarterly earnings results on Thursday, June 29th. The pharmacy operator reported $1.33 EPS for the quarter, topping the Zacks’ consensus estimate of $1.30 by $0.03. The business had revenue of $30.12 billion during the quarter, compared to analysts’ expectations of $29.72 billion. Walgreens Boots Alliance had a net margin of 3.69% and a return on equity of 17.34%. The business’s quarterly revenue was up 2.1% compared to the same quarter last year. During the same quarter in the previous year, the company earned $1.18 EPS. Analysts anticipate that Walgreens Boots Alliance, Inc. will post $5.00 EPS for the current year.

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, September 12th. Stockholders of record on Friday, August 18th were given a dividend of $0.40 per share. The ex-dividend date was Wednesday, August 16th. This represents a $1.60 annualized dividend and a dividend yield of 2.07%. This is a boost from Walgreens Boots Alliance’s previous quarterly dividend of $0.38. Walgreens Boots Alliance’s dividend payout ratio (DPR) is 40.30%.

Walgreens Boots Alliance announced that its board has authorized a share buyback program on Thursday, June 29th that permits the company to repurchase $5.00 billion in shares. This repurchase authorization permits the pharmacy operator to buy up to 5.9% of its stock through open market purchases. Stock repurchase programs are generally a sign that the company’s board of directors believes its stock is undervalued.

TRADEMARK VIOLATION NOTICE: This piece of content was first posted by Watch List News and is the sole property of of Watch List News. If you are reading this piece of content on another domain, it was illegally stolen and reposted in violation of international copyright and trademark laws. The original version of this piece of content can be read at https://www.watchlistnews.com/endurance-wealth-management-inc-has-1969000-stake-in-walgreens-boots-alliance-inc-wba/1602144.html.

Several equities research analysts recently issued reports on WBA shares. Needham & Company LLC set a $94.00 price target on Walgreens Boots Alliance and gave the company a “buy” rating in a research note on Monday, July 17th. Credit Suisse Group reissued a “buy” rating and set a $97.00 price target on shares of Walgreens Boots Alliance in a research report on Thursday, July 13th. Leerink Swann set a $86.00 price objective on Walgreens Boots Alliance and gave the stock a “buy” rating in a research note on Friday, July 7th. Citigroup Inc. restated a “buy” rating on shares of Walgreens Boots Alliance in a research note on Monday, July 3rd. Finally, Guggenheim restated a “buy” rating on shares of Walgreens Boots Alliance in a research note on Monday, July 3rd. Two research analysts have rated the stock with a sell rating, four have assigned a hold rating and fifteen have assigned a buy rating to the company’s stock. Walgreens Boots Alliance currently has an average rating of “Buy” and an average price target of $92.06.

In other news, Director William C. Foote sold 2,736 shares of Walgreens Boots Alliance stock in a transaction on Tuesday, July 25th. The shares were sold at an average price of $79.79, for a total transaction of $218,305.44. Following the completion of the sale, the director now directly owns 19,151 shares of the company’s stock, valued at approximately $1,528,058.29. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Company insiders own 13.50% of the company’s stock.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.